The potential adding therapeutic effect of pentoxifylline and/or folic acid for chronic kidney disease patients: randomized controlled trial
Our results demonstrated that administration of therapeutic doses of PTX and/or FA in CKD patients delayed the progression of advanced chronic kidney disease and has been used successfully improved their health-related quality of life.
Authors
- Ahmed Aljabri (ORCID: https://orcid.org/0000-0002-7049-9826)
- Nahla Mohamed Teama (ORCID: https://orcid.org/0000-0003-0095-8721)
- Karema Abu‐Elfotuh (ORCID: https://orcid.org/0000-0003-3870-3206)
- Hanan Alshareef (ORCID: https://orcid.org/0000-0002-1264-7229)
- Ahmed D. Alatawi (ORCID: https://orcid.org/0000-0001-6459-9700)
- Mohannad Alshibani (ORCID: https://orcid.org/0000-0002-3997-676X)
- Ashraf Galal (ORCID: https://orcid.org/0000-0002-3752-089X)
- Ahmed M. Hamdan (ORCID: https://orcid.org/0000-0003-4930-792X)
- Zeinab Zalat
Institutions
- Ain Shams University (EG)
- Al-Azhar University (EG)
- King Abdulaziz University (SA)
- Jouf University (SA)
- Fahd bin Sultan University (SA)
- University of Tabuk (SA)
Publication Details
- Journal
- BMC Nephrology
- Published
- 2025-08-18
- DOI
- https://doi.org/10.1186/s12882-025-04399-3
- Citations
- 2
- Primary Topic
- Folate and B Vitamins Research
- Type
- article
- Field-Weighted Citation Impact
- 3.34
Funders
- Ain Shams University
- Al-Azhar University